These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30971214)

  • 1. A cohort study of the association between maternal serum Inhibin-A and adverse pregnancy outcomes: a population-based study.
    Singnoi W; Wanapirak C; Sekararithi R; Tongsong T
    BMC Pregnancy Childbirth; 2019 Apr; 19(1):124. PubMed ID: 30971214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are serum levels of inhibin A in second trimester predictors of adverse pregnancy outcome?
    Yue CY; Zhang CY; Ni YH; Ying CM
    PLoS One; 2020; 15(5):e0232634. PubMed ID: 32469905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes.
    Settiyanan T; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
    J Matern Fetal Neonatal Med; 2016; 29(13):2093-7. PubMed ID: 27480207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
    Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
    J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.
    Jelliffe-Pawlowski LL; Baer RJ; Blumenfeld YJ; Ryckman KK; O'Brodovich HM; Gould JB; Druzin ML; El-Sayed YY; Lyell DJ; Stevenson DK; Shaw GM; Currier RJ
    BJOG; 2015 Oct; 122(11):1484-93. PubMed ID: 26111589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases.
    Petraglia F; Luisi S; Benedetto C; Zonca M; Florio P; Casarosa E; Volpe A; Bernasconi S; Genazzani AR
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2991-5. PubMed ID: 9284732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies.
    Keelan JA; Taylor R; Schellenberg JC; Groome NP; Mitchell MD; North RA
    Obstet Gynecol; 2002 Feb; 99(2):267-74. PubMed ID: 11814508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes.
    Sirikunalai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
    J Obstet Gynaecol; 2016; 36(2):178-82. PubMed ID: 26368010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels.
    Puntachai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
    Arch Gynecol Obstet; 2015 Jul; 292(1):81-5. PubMed ID: 25547063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
    Smith GC; Crossley JA; Aitken DA; Jenkins N; Lyall F; Cameron AD; Connor JM; Dobbie R
    Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction?
    D'Anna R; Baviera G; Corrado F; Leonardi I; Buemi M; Jasonni VM
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):540-3. PubMed ID: 12047308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2D-Ultrasound and endocrinologic evaluation of placentation in early pregnancy and its relationship to fetal birthweight in normal pregnancies and pre-eclampsia.
    Suri S; Muttukrishna S; Jauniaux E
    Placenta; 2013 Sep; 34(9):745-50. PubMed ID: 23756051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First trimester sex hormone-binding globulin and subsequent development of preeclampsia or other adverse pregnancy outcomes.
    Spencer K; Yu CK; Rembouskos G; Bindra R; Nicolaides KH
    Hypertens Pregnancy; 2005; 24(3):303-11. PubMed ID: 16263602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A.
    Tul N; Pusenjak S; Osredkar J; Spencer K; Novak-Antolic Z
    Prenat Diagn; 2003 Dec; 23(12):990-6. PubMed ID: 14663836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.